
Ansun BioPharma, a San Diego-based clinical stage biopharmaceutical company, develops host-directed anti-viral therapies.
Ansun BioPharma, based in San Diego, is a clinical stage biopharmaceutical company dedicated to developing host-directed anti-viral therapies. The company focuses on addressing unmet medical needs in the treatment of respiratory viruses, including pandemic and drug-resistant variants, as well as combating cancer. Ansun BioPharma's mission is to innovate therapeutics that significantly improve patient health through industry-leading research.
Ansun BioPharma has made significant strides in its field, with ongoing clinical trials aimed at validating their therapeutic approaches. The company's impact is underscored by its commitment to addressing critical health challenges and improving patient outcomes. Through its pioneering research and development efforts, Ansun BioPharma continues to position itself as a leader in the biopharmaceutical industry.

Antios Therapeutics

Ansata Therapeutics

Enanta Pharmaceuticals
enanta.com

Therabiol

Retrovirox
retrovirox.com

Theravance Biopharma
theravance.com

Arisan Therapeutics
arisanthera.com

Antiva Biosciences
antivabio.com

Andson Biotech
andsonbiotech.com

Clear Creek Bio
clearcreekbio.com

AnaptysBio
anaptysbio.com

Santa Ana Bio
santaanabio.com

Altesa
altesabio.com

SunnyBay BioTech

Vir Biotechnology
vir.bio
Companies similar to Ansun Biopharma include Antios Therapeutics, Ansata Therapeutics, Enanta Pharmaceuticals and Therabiol.
Ansun Biopharma was founded in 2002.
Ansun Biopharma's headquarters is located in San Diego, CA, US.
Ansun Biopharma's most recent funding round was for $100M (USD) in October 2019.
As of Oct 15, 2019, Ansun Biopharma has raised a total of $213.1M (USD).
Ansun Biopharma has 27 employees as of Feb 5, 2024.